financetom
Business
financetom
/
Business
/
Nazara says there will be new gaming IPs in the next six months
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nazara says there will be new gaming IPs in the next six months
Nov 22, 2023 5:44 AM

Mumbai-based Nazara Technologies is looking at more acquisitions to beef up its gaming and e-sports business, which together contributed over 86% of its total revenue as of the financial year ending March 2023.

Share Market Live

NSE

“We have built a strong pipeline, especially in core gaming studio IPs, eSports space and perhaps a little bit in Adtech as well. We are looking at all these opportunities and hope to conclude some transactions in the next couple of quarters,” Nitish Mittersain, Joint MD & CEO of Nazara Technologies.

The recent imposition of goods and services tax (GST) on gaming companies spooked many of the players in the sector.

However, for Nazara, real money gaming, which includes Classic Rummy, made up 4% of its revenue. The rest of this segment (which had a revenue of over ₹400 crore in FY23) was from the gamified education platform for kids, Kiddopia, among others.

The e-sports vertical includes Nodwin, PublishME in the Turkey/MENA market, and Sportskeeda and Pro Football Network.

The company’s strategy has been to buy out or invest in games.

“Much of the capital will be used for driving additional M&A. Nazara has a strategy of acquire and grow, which has worked very well and we are surely going to double down on that,” he said.

Mittersain also believes that the number of gamers in the country will go up to 750 million by 2027 from the current 500 million.

“We have about 500 million gamers today, which are expected to grow to 750 million gamers by 2027. Gamers are spending today, 100 minutes on average a day playing games, which is much more than time spent on OTT and TV etc,” he said.

Nazara Technologies is a small-cap company with a market capitalisation of ₹5,876.72 crore, operating within the services sector.

For more, watch the accompanying video

(Edited by : Sriram Iyer)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exicure Gets Patent in Australia for Potential Cancer Treatment Combination
Exicure Gets Patent in Australia for Potential Cancer Treatment Combination
Mar 14, 2025
04:20 AM EDT, 03/14/2025 (MT Newswires) -- Exicure ( XCUR ) said late Thursday it received a patent in Australia covering its combination approach to cancer treatment, specifically targeting CXCR4 and GPCRx. The patent supports the company's ongoing phase 2 clinical trial assessing the combination of GPC-100 and propranolol to treat multiple myeloma, a cancer of plasma cells. ...
Kering shares down 10% after appointment of Demna as Gucci designer
Kering shares down 10% after appointment of Demna as Gucci designer
Mar 14, 2025
PARIS (Reuters) - Kering shares tanked on Friday morning after the group led by Francois-Henri Pinault chose to bet on subversive in-house talent Demna to reinvigorate its Gucci label rather than hiring a big-ticket name from fashion's overheating job market. Shares fell by around 10% in early Paris session trade, underperforming French luxury peers which were trading flat following the...
Hong Kong's CK Hutchison under fire after China criticism of ports sale to US
Hong Kong's CK Hutchison under fire after China criticism of ports sale to US
Mar 14, 2025
* State-owned media commentary calls port sale a betrayal * China's Hong Kong and Macau Affairs Office reposts commentary * CK Hutchison ( CKHUF ) shares drop 6.4% * Comments highlight political risks for HK firms, analysts say (Updates share prices) By Clare Jim and James Pomfret HONG KONG, March 14 (Reuters) - China's Hong Kong and Macau Affairs Office...
Sutro Biopharma Names New CEO; Plans to Reduce Workforce by Nearly 50% After Portfolio Review
Sutro Biopharma Names New CEO; Plans to Reduce Workforce by Nearly 50% After Portfolio Review
Mar 14, 2025
04:21 AM EDT, 03/14/2025 (MT Newswires) -- Sutro Biopharma ( STRO ) said late Thursday it appointed Jane Chung as its new chief executive and plans to nearly halve its workforce, following a strategic review of the company's portfolio. Chung, who was chief operating officer of the company, will succeed Bill Newell as CEO, effective March 13. Newell will remain...
Copyright 2023-2026 - www.financetom.com All Rights Reserved